MIAMI LAKES, Fla., March 5, 2013 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP) (www.fusescience.com) a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals announced the implementation of initiatives to support execution of its national roll-out strategy for PowerFuse™, ElectroFuse™ and EnerJel™.
"Since our partnership with Daymond John and the Shark Branding team, there has been a marked acceleration of the business," stated Brian Tuffin, CEO Fuse Science. "Our strategy is very specific and focused on the national expansion of our product portfolio and advancement of licensing opportunities for our proprietary technology. An investment is being made to expand production capacity of our DROP technology products comparable to that undertaken last summer for the EnerJel™ brand. This will allow for the production of millions of units of our PowerFuse™ and ElectroFuse™ products to support the pipeline we expect to develop through our planned national retail partnerships, which we anticipate announcing in the near future. Our goal is to have our DROP products in 10,000 retail locations by the end of the third calendar quarter of 2013 and in over 15,000 retail locations by the end of the fourth quarter. A portion of the proceeds from our recently announced capital infusion will be used to fund this strategy. We believe that the national rollout strategy will afford us the opportunity to achieve significant revenue growth.
"Management fully understands the ongoing need for capital to facilitate growth in an accelerated environment. Given the reported margin strength of the Company, there is a systemic focus in becoming cash flow positive ahead in the near term, which we believe will set forth the stage for self-sustainability," added Tuffin.
About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida. Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).
Safe Harbor Statement
Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.
SOURCE Fuse Science, Inc.